VITA — Vitaminka AD Prilep Balance Sheet
0.000.00%
Last trade - 00:00- MKD928.25m
- MKD2.68bn
- MKD4.61bn
Annual balance sheet for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20.8 | 15.3 | 24.7 | 37.9 | 31.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 641 | 725 | 668 | 737 | 1,041 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,321 | 1,486 | 1,507 | 1,605 | 1,944 |
| Net Property, Plant And Equipment | 1,429 | 1,545 | 1,507 | 1,543 | 1,736 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,915 | 3,121 | 3,194 | 3,457 | 4,009 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 903 | 1,045 | 1,063 | 1,198 | 1,494 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,923 | 2,146 | 2,101 | 2,197 | 2,775 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 991 | 976 | 1,093 | 1,260 | 1,234 |
| Total Liabilities & Shareholders' Equity | 2,915 | 3,121 | 3,194 | 3,457 | 4,009 |
| Total Common Shares Outstanding |